Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

MS-Autoimmune
Albert Aboseif, D.O.  
"Cognitive Impairment in Multiple Sclerosis"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Describe the prevalence of cognitive impairment across the multiple sclerosis disease course
• Determine the best tools for measuring multiple sclerosis-related cognitive impairment and common cognitive domains affected    
• Determine the significance of cognitive impairment in early and asymptomatic forms of multiple sclerosis
• Describe the radiological and neuropathological surrogates of cognitive impairment
• Explore the impact of disease modifying therapy on cognitive impairment in multiple sclerosis
• Define tangible solutions for improving cognitive impairment in multiple sclerosis

Dr. Aboseif does not have any relevant financial relationships to disclose and does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.